Status:
COMPLETED
Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS
Lead Sponsor:
Sahlgrenska University Hospital
Collaborating Sponsors:
University Hospital, Antwerp
Universitair Ziekenhuis Brussel
Conditions:
Diabetes Mellitus Type 2 in Obese
Eligibility:
All Genders
18-65 years
Brief Summary
Describe and characterize the time-course for improvement in glucose control after bariatric surgery in obese patients with type 2 diabetes Compare these changes in glycemic control after different t...
Detailed Description
Obesity and its ensuing metabolic complications such as type 2 diabetes mellitus, are exponentially increasing worldwide. \* \* The most effective treatment for obesity is bariatric surgery. \* Differ...
Eligibility Criteria
Inclusion
- Male and female type 2 diabetic patients
- Patients aged 18-65 years
- Diabetes treatment consisting of dietary measures or any of the following:
- Metformin
- Sulfonylurea
- Glinides
- Glitazones
- Acarbose
- Any type of insulin
- BMI ≥ 35 kg/m2
Exclusion
- Active alcohol abuse
- Active psychiatric illness
- MODY (maturity onset diabetes of the young)
- Type 1 diabetes
- Diabetes treatment consisting of DPP IV-inhibitors or incretin mimetics
- Pregnancy and gestational diabetes
- Prior bariatric surgery
Key Trial Info
Start Date :
September 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04314427
Start Date
September 1 2012
End Date
March 1 2018
Last Update
March 19 2020
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Antwerp, Edegem, Belgium, B-2650
2
Universitair Ziekenhuis
Brussels, Jette, Belgium, B-1090
3
Gent University Hospital
Ghent, Belgium, B-9000
4
Hospital Clinico San Carlos
Madrid, Spain